Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-03-11 | TALPHERA, INC. | Angotti Vincent J.
(CHIEF EXECUTIVE OFFICER) |
A | Common Stock | A | 9000 | $1.11 - $1.12 | $10,110 |
2024-03-03 | TALPHERA, INC. | Dasu Badri N
(Chief Engineering Officer) |
F | Common Stock | D | 406 | $1.30 - $1.30 | $527 |
2024-03-03 | TALPHERA, INC. | Palmer Pamela P
(Chief Medical Officer) |
F | Common Stock | D | 450 | $1.30 - $1.30 | $585 |
2024-03-03 | TALPHERA, INC. | ASADORIAN RAFFI
(Chief Financial Officer) |
F | Common Stock | D | 558 | $1.30 - $1.30 | $725 |
2024-03-03 | TALPHERA, INC. | Angotti Vincent J.
(Chief Executive Officer) |
F | Common Stock | D | 1623 | $1.30 - $1.30 | $2,109 |
2024-02-14 | TALPHERA, INC. | Palmer Pamela P
(Chief Medical Officer) |
A | Common Stock | A | 18000 | $0.00 - $0.00 | $0 |
2024-02-14 | TALPHERA, INC. | Dasu Badri N
(Chief Engineering Officer) |
A | Common Stock | A | 14667 | $0.00 - $0.00 | $0 |
2024-02-14 | TALPHERA, INC. | ASADORIAN RAFFI
(Chief Financial Officer) |
A | Common Stock | A | 18000 | $0.00 - $0.00 | $0 |
2024-02-14 | TALPHERA, INC. | Angotti Vincent J.
(Chief Executive Officer) |
A | Common Stock | A | 58667 | $0.00 - $0.00 | $0 |
2024-02-10 | TALPHERA, INC. | Dasu Badri N
(Chief Engineering Officer) |
F | Common Stock | D | 1618 | $1.10 - $1.10 | $1,778 |
2024-02-10 | TALPHERA, INC. | Palmer Pamela P
(Chief Medical Officer) |
F | Common Stock | D | 1602 | $1.10 - $1.10 | $1,762 |
2024-02-10 | TALPHERA, INC. | ASADORIAN RAFFI
(Chief Financial Officer) |
F | Common Stock | D | 1790 | $1.10 - $1.10 | $1,968 |
2024-02-10 | TALPHERA, INC. | Angotti Vincent J.
(Chief Executive Officer) |
F | Common Stock | D | 7043 | $1.10 - $1.10 | $7,747 |
2024-01-22 | TALPHERA, INC. | JAIN ABHINAV
(Director) |
A | Common Stock | A | 871 | $0.00 - $0.00 | $0 |
2023-12-13 | ACELRX PHARMACEUTICALS INC | Angotti Vincent J.
(Chief Executive Officer) |
P | Common Stock | A | 10000 | $0.73 - $0.73 | $7,268 |
2023-10-10 | ACELRX PHARMACEUTICALS INC | WAN MARK A
(Director) |
A | Common Stock | A | 581 | $0.00 - $0.00 | $0 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |